What should happen is the stock should be suspended and trading activity reviewed. ASXs non-action on this as it was rapidly rising on massive volumes was farcical.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential